Company news

Assembly Biosciences, Inc. news in 2019

Assembly Biosciences, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Assembly Biosciences Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

December 15, 2019

Assembly Biosciences Announces Pricing of $125 Million Public Offering

December 11, 2019

Assembly Biosciences Announces Proposed Public Offering of Common Stock

December 10, 2019

Assembly Biosciences Announces Plenary Lecture at HEP DART 2019

December 5, 2019

Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

November 6, 2019

Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer

November 6, 2019

Assembly Biosciences Appoints Thomas J. Russo as Chief Financial Officer

October 27, 2019

Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019

April 12, 2019

Decks in 2019